Investors.niox.com is a subdomain of niox.com, which was created on 1999-11-29,making it 24 years ago.
Description:Our ‘FeNO by NIOX®’ range helps physicians around the world see airway inflammation clearly, helping improve asthma diagnosis and...
Discover investors.niox.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 89.787 KB |
Page Load Time: 0.483687 Seconds |
Website IP Address: 35.214.46.49 |
Mind Body Wellness Group, LLC | CarePaths EHR and Measurement Based Care stone.carepaths.com |
Debt Monitoring Hub – Debt Monitoring Hub debthub.cpdcngo.org |
TestMart - the leading government procurement resource for test and measurement equipment on GSA Sch vidsys.gsamart.com |
e-monitoring networks remote monitoring and asset management owrd.e-monitoring.net |
A new generation of allergy treatments https://investors.niox.com/wp-content/uploads/2015/03/CIR-Annual-Report-2014.pdf |
Circassia Group plc https://investors.niox.com/wp-content/uploads/2021/03/circassia-2020-Strategic-Report-final.pdf |
Investors - NIOX® https://investors.niox.com/investors/ |
Financial reports - NIOX® https://investors.niox.com/investors/financial-reports/ |
NIOX Group plc: The leading provider of point-of-care FeNO measurement ... https://investors.niox.com/ |
PDF Annual Report & Accounts https://investors.niox.com/wp-content/uploads/2024/03/NIOX-Annual-Report-2023-final.pdf |
Company - NIOX® https://investors.niox.com/company/ |
Press releases - NIOX® https://investors.niox.com/media/press-releases/ |
PDF NIOX Group plc Interim Report & Accounts https://investors.niox.com/wp-content/uploads/2023/09/NIOX-Interim-Report-2023-FINAL.pdf |
Investor presentations Archives - NIOX® https://investors.niox.com/resource/category/presentations/ |
PDF NIOX GROUP PLC NIOX Company Group INTERIM RESULTS FOR THE SIX MONTHS ... https://investors.niox.com/wp-content/uploads/2022/09/CIR-PR-XX_Interim-Results-2022-FINAL.pdf |
Financial calendar - NIOX® https://investors.niox.com/investors/financial-calendar/ |
Our Products - About NIOX® https://investors.niox.com/products/ |
Management team - NIOX® https://investors.niox.com/company/management-team/ |
Share price summary - NIOX® https://investors.niox.com/investors/share-price-summary/ |
Server: nginx |
Date: Tue, 14 May 2024 06:59:50 GMT |
Content-Type: text/html; charset=UTF-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Vary: Accept-Encoding |
X-Cache-Enabled: True |
Link: https://investors.niox.com/wp-json/; rel="https://api.w.org/", https://investors.niox.com/wp-json/wp/v2/pages/4405; rel="alternate"; type="application/json", https://investors.niox.com/; rel=shortlink |
X-Httpd-Modphp: 1 |
Cache-Control: no-cache |
Host-Header: 6b7412fb82ca5edfd0917e3957f05d89 |
X-Proxy-Cache: MISS |
X-Proxy-Cache-Info: 0 NC:000000 UP: |
charset="utf-8"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots" |
content="Our ‘FeNO by NIOX®’ range helps physicians around the world see airway inflammation clearly, helping improve asthma diagnosis and management." name="description" |
content="en_US" property="og:locale"/ |
content="website" property="og:type"/ |
content="NIOX Group plc: The leading provider of point-of-care FeNO measurement and monitoring" property="og:title"/ |
content="Our ‘FeNO by NIOX®’ range helps physicians around the world see airway inflammation clearly, helping improve asthma diagnosis and management." property="og:description"/ |
content="https://investors.niox.com/" property="og:url"/ |
content="NIOX®" property="og:site_name"/ |
content="2023-10-27T11:46:20+00:00" property="article:modified_time"/ |
content="https://investors.niox.com/wp-content/uploads/2021/04/Circassia-test.jpeg" property="og:image"/ |
content="summary_large_image" name="twitter:card"/ |
content="WordPress 6.5.3" name="generator"/ |
content="https://investors.niox.com/wp-content/uploads/2022/08/cropped-favicon-270x270.png" name="msapplication-TileImage"/ |
Ip Country: United Kingdom |
City Name: London |
Latitude: 51.5088 |
Longitude: -0.093 |
menu Company About NIOX Group plc Company profile Board of directors Company scientific advisor Management team Corporate responsibility Products Our products Product contacts Investors Investor centre Company profile Regulatory news Share price chart Share price summary Financial reports Financial calendar Registrars AIM rule 26 Analyst coverage Email alerts Investor contacts Investor presentations Shareholder Documents Media Press releases Company profile Media contacts Careers Global opportunities Job Applicant Privacy Notice Contacts Locations Product contacts Investor contacts Media contacts Career Contacts search Dedicated to point of care asthma diagnosis and management Our ambition is to improve the quality of life of millions of people suffering from asthma. With our gold standard NIOX device we are making good progress. Previous chevron_left Dedicated to point of care asthma diagnosis and management Next chevron_right The leading provider of point-of-care FeNO measurement and monitoring Our ‘FeNO by NIOX®’ range helps physicians around the world see airway inflammation clearly, helping improve asthma diagnosis and management. Previous chevron_left The leading provider of point-of-care FeNO measurement and monitoring Next chevron_right A worldwide network of support Our NIOX® products are available in over 50 countries, where we offer outstanding customer support through our dedicated local teams and network of distributors. Previous chevron_left A worldwide network of support Next chevron_right NIOX VERO® – The gold standard in FeNO Testing With millions of FeNO tests performed worldwide, NIOX® technology helps healthcare professionals to accurately measure airway inflammation at the point of care. Visit NIOX.com to learn more 50m tests completed with NIOX® technology We are immensely proud to announce that the healthcare community reached 45 million FeNO tests completed with NIOX® technology. Find out more on NIOX.com Celebrating 25 years of NIOX® technology! As an organisation, we are proud to be celebrating 25 years of NIOX® technology. From the launch of the first NIOX® device in 1998 through to today, learn more about our company’s story: Discover the NIOX® story Company About NIOX Group plc Company profile Board of directors Company scientific advisor Management team Corporate responsibility Products Products Product contacts Investors Investor centre Regulatory news Share price chart Share price summary Financial reports Financial calendar Registrars AIM rule 26 Analyst coverage Email alerts Investor contacts Investor presentations Shareholder Documents Media Press releases Company Profile Media contacts Careers Global opportunities Career Contacts Job Applicant Privacy Notice Contacts Locations UK Head Office US Headquarters Swedish Headquarters China Headquarters German Headquarters Product contacts Investor contacts Media contacts Career Contacts Legal Legal notice Privacy Notice Accessibility Notice Responsible Disclosures Code of conduct Job Applicant Privacy Notice California declaration © 2024 NIOX®. All Rights Reserved. Site map Cookie settings Twitter...
Domain Name: NIOX.COM Registry Domain ID: 14166472_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domaininfo.com Registrar URL: http://www.abion.com Updated Date: 2023-11-22T23:03:26Z Creation Date: 1999-11-29T10:52:57Z Registry Expiry Date: 2024-11-29T10:52:57Z Registrar: Abion AB Registrar IANA ID: 73 Registrar Abuse Contact Email: abuse@abion.com Registrar Abuse Contact Phone: +46707260015 Domain Status: ok https://icann.org/epp#ok Name Server: NS1.DUSTINDNS.NET Name Server: NS1.DUSTINDNS.NL Name Server: NS1.DUSTINDNS.SE DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:27:03Z <<<